vs

Side-by-side financial comparison of Alector, Inc. (ALEC) and CSP INC (CSPI). Click either name above to swap in a different company.

CSP INC is the larger business by last-quarter revenue ($12.0M vs $6.2M, roughly 1.9× Alector, Inc.). On growth, CSP INC posted the faster year-over-year revenue change (-23.2% vs -88.5%). CSP INC produced more free cash flow last quarter ($-3.0M vs $-184.1M). Over the past eight quarters, CSP INC's revenue compounded faster (-6.3% CAGR vs -37.4%).

Alector, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for neurodegenerative diseases. Its product pipeline targets unmet medical needs including Alzheimer’s disease, frontotemporal dementia, and Parkinson’s disease, and it collaborates with global pharmaceutical partners to advance candidate therapies through clinical trials.

CSP Inc. is a U.S.-based technology firm offering cybersecurity solutions, managed IT services, high-performance computing systems, and IT consulting support. It serves enterprises across healthcare, finance, manufacturing, and public sectors in North America and select global markets.

ALEC vs CSPI — Head-to-Head

Bigger by revenue
CSPI
CSPI
1.9× larger
CSPI
$12.0M
$6.2M
ALEC
Growing faster (revenue YoY)
CSPI
CSPI
+65.3% gap
CSPI
-23.2%
-88.5%
ALEC
More free cash flow
CSPI
CSPI
$181.1M more FCF
CSPI
$-3.0M
$-184.1M
ALEC
Faster 2-yr revenue CAGR
CSPI
CSPI
Annualised
CSPI
-6.3%
-37.4%
ALEC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ALEC
ALEC
CSPI
CSPI
Revenue
$6.2M
$12.0M
Net Profit
$91.0K
Gross Margin
39.3%
Operating Margin
-0.9%
Net Margin
0.8%
Revenue YoY
-88.5%
-23.2%
Net Profit YoY
-1696.9%
-80.7%
EPS (diluted)
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALEC
ALEC
CSPI
CSPI
Q4 25
$6.2M
$12.0M
Q3 25
$3.3M
$14.5M
Q2 25
$7.9M
$15.4M
Q1 25
$3.7M
$13.1M
Q4 24
$54.2M
$15.7M
Q3 24
$15.3M
$13.0M
Q2 24
$15.1M
$13.1M
Q1 24
$15.9M
$13.7M
Net Profit
ALEC
ALEC
CSPI
CSPI
Q4 25
$91.0K
Q3 25
$-34.7M
$-191.0K
Q2 25
$-30.5M
$-264.0K
Q1 25
$-40.5M
$-108.0K
Q4 24
$-2.1M
$472.0K
Q3 24
$-42.2M
$-1.7M
Q2 24
$-38.7M
$-185.0K
Q1 24
$-36.1M
$1.6M
Gross Margin
ALEC
ALEC
CSPI
CSPI
Q4 25
39.3%
Q3 25
36.6%
Q2 25
28.8%
Q1 25
32.0%
Q4 24
29.1%
Q3 24
28.4%
Q2 24
35.0%
Q1 24
47.3%
Operating Margin
ALEC
ALEC
CSPI
CSPI
Q4 25
-0.9%
Q3 25
-1153.6%
-3.7%
Q2 25
-433.6%
-7.9%
Q1 25
-1216.5%
-7.6%
Q4 24
-13.4%
-2.3%
Q3 24
-315.7%
-15.7%
Q2 24
-302.4%
-5.5%
Q1 24
-275.0%
9.0%
Net Margin
ALEC
ALEC
CSPI
CSPI
Q4 25
0.8%
Q3 25
-1063.4%
-1.3%
Q2 25
-387.7%
-1.7%
Q1 25
-1101.6%
-0.8%
Q4 24
-3.8%
3.0%
Q3 24
-275.2%
-12.7%
Q2 24
-256.4%
-1.4%
Q1 24
-227.0%
11.6%
EPS (diluted)
ALEC
ALEC
CSPI
CSPI
Q4 25
$0.01
Q3 25
$-0.34
$-0.02
Q2 25
$-0.30
$-0.03
Q1 25
$-0.41
$-0.01
Q4 24
$-0.02
$0.05
Q3 24
$-0.43
$-0.17
Q2 24
$-0.40
$-0.02
Q1 24
$-0.38
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALEC
ALEC
CSPI
CSPI
Cash + ST InvestmentsLiquidity on hand
$256.0M
$24.9M
Total DebtLower is stronger
$10.0M
Stockholders' EquityBook value
$30.6M
$44.8M
Total Assets
$293.2M
$69.2M
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALEC
ALEC
CSPI
CSPI
Q4 25
$256.0M
$24.9M
Q3 25
$291.1M
$27.4M
Q2 25
$307.3M
$26.3M
Q1 25
$354.6M
$29.5M
Q4 24
$413.4M
$30.7M
Q3 24
$457.2M
$30.6M
Q2 24
$503.3M
$28.9M
Q1 24
$562.1M
$27.1M
Total Debt
ALEC
ALEC
CSPI
CSPI
Q4 25
$10.0M
Q3 25
Q2 25
Q1 25
Q4 24
$10.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ALEC
ALEC
CSPI
CSPI
Q4 25
$30.6M
$44.8M
Q3 25
$57.7M
$44.6M
Q2 25
$71.2M
$47.5M
Q1 25
$94.6M
$47.5M
Q4 24
$126.8M
$47.5M
Q3 24
$118.9M
$47.3M
Q2 24
$150.6M
$48.1M
Q1 24
$178.9M
$48.2M
Total Assets
ALEC
ALEC
CSPI
CSPI
Q4 25
$293.2M
$69.2M
Q3 25
$335.3M
$71.2M
Q2 25
$356.4M
$66.8M
Q1 25
$408.3M
$67.1M
Q4 24
$468.3M
$67.5M
Q3 24
$516.0M
$69.4M
Q2 24
$570.7M
$66.8M
Q1 24
$635.5M
$64.2M
Debt / Equity
ALEC
ALEC
CSPI
CSPI
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
0.08×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALEC
ALEC
CSPI
CSPI
Operating Cash FlowLast quarter
$-184.0M
$-2.9M
Free Cash FlowOCF − Capex
$-184.1M
$-3.0M
FCF MarginFCF / Revenue
-2951.3%
-25.1%
Capex IntensityCapex / Revenue
0.7%
0.9%
Cash ConversionOCF / Net Profit
-32.04×
TTM Free Cash FlowTrailing 4 quarters
$-326.5M
$-2.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALEC
ALEC
CSPI
CSPI
Q4 25
$-184.0M
$-2.9M
Q3 25
$-32.5M
$1.9M
Q2 25
$-49.0M
$-3.3M
Q1 25
$-60.8M
$1.9M
Q4 24
$-55.0M
$1.7M
Q3 24
$-50.7M
$-1.5M
Q2 24
$-62.8M
$2.4M
Q1 24
$-61.3M
$1.7M
Free Cash Flow
ALEC
ALEC
CSPI
CSPI
Q4 25
$-184.1M
$-3.0M
Q3 25
$-32.5M
$1.7M
Q2 25
$-49.1M
$-3.3M
Q1 25
$-60.8M
$1.9M
Q4 24
$-55.2M
$1.7M
Q3 24
$-50.9M
$-1.5M
Q2 24
$-63.1M
$2.4M
Q1 24
$-61.9M
$1.6M
FCF Margin
ALEC
ALEC
CSPI
CSPI
Q4 25
-2951.3%
-25.1%
Q3 25
-997.6%
11.5%
Q2 25
-623.0%
-21.7%
Q1 25
-1655.0%
14.5%
Q4 24
-101.8%
10.8%
Q3 24
-332.1%
-11.7%
Q2 24
-418.6%
17.9%
Q1 24
-389.3%
11.9%
Capex Intensity
ALEC
ALEC
CSPI
CSPI
Q4 25
0.7%
0.9%
Q3 25
0.3%
1.6%
Q2 25
0.1%
0.4%
Q1 25
0.5%
0.1%
Q4 24
0.3%
0.3%
Q3 24
1.4%
0.1%
Q2 24
2.2%
0.3%
Q1 24
3.4%
0.1%
Cash Conversion
ALEC
ALEC
CSPI
CSPI
Q4 25
-32.04×
Q3 25
Q2 25
Q1 25
Q4 24
3.69×
Q3 24
Q2 24
Q1 24
1.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALEC
ALEC

Segment breakdown not available.

CSPI
CSPI

Products$6.7M56%
Services$5.3M44%

Related Comparisons